CanaQuest is primed to realize the infinite potential of targeted therapeutics within the endocannabinoid system and specific brain receptors to mediated signaling pathways.
DRUG CANDIDATE FORMULATIONS
A critical mass of clinical evidence regarding the efficacy of medical cannabinoids is refuting political, scientific, and other skeptics, and opening minds hardened by decades of anti-cannabis propaganda. Our goal is to develop better alternative treatments to traditional pharmaceuticals for people struggling with a variety of health challenges.
CQ-001, Drug Candidate – Epilepsy(CBD molecules + formula) Clinical-trial stage Supports anxiety, depression, schizophrenia, PTSD and addiction |
CQ-002, Drug Candidate – Safer alternative(THC molecules + formula) Clinical-trial stage Supports mental health: safer alternative to THC by itself |
CQ-003, Drug Candidate – Pain(CBD molecules + formula) In development To support inflammation & pain |
CQ-004, Drug Candidate – Alzheimer’s(THC + CBD molecules + formula) In development To support mental health |